• Mashup Score: 1
    Social Determinants of Health and Racial Disparities in Cardiac Events in Breast Cancer - 1 year(s) ago

    Background: Racial disparities have been reported for breast cancer and cardiovascular disease (CVD) outcomes. The determinants of racial disparities in CVD outcomes are not yet fully understood. We aimed to examine the impact of individual and neighborhood-level social determinants of health (SDOH) on the racial disparities in major adverse cardiovascular events (MACE; consisting of heart…

    Source: JNCCN
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of OncoAlert
      OncoAlert

      RT @avirupguha: I thank all co-authors for their incredible contribution. find the article here: https://t.co/2pGd6Z87Xz Excellent editor…

  • Mashup Score: 0
    Best Practices for Addressing the Health Needs of the LGBTQ+ Community in Oncology Care - 1 year(s) ago

    Patients with cancer in the LGBTQ+ community experience worse health outcomes when compared with their non-LGBTQ+ peers because of a variety of factors, including stigma, underrepresentation in research, lack of support, and implicit bias on the part of clinicians. For generations, many LGBTQ+ people have feared disclosing their identity to providers, leading to gaps in care and even higher…

    Source: JNCCN
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of DarcyBurbage
      DarcyBurbage

      Best Practices for Addressing the Health Needs of the LGBTQ+ Community in Oncology Care ⁦@JNCCN⁩ ⁦@oncologynursing⁩ ⁦@OncoAlert⁩ https://t.co/QHLHJWWetF

  • Mashup Score: 0
    Prognostic and Predictive Markers for Patients With Anal Cancer - 1 year(s) ago

    Squamous cell carcinoma of the anus and anal canal is a rare malignancy with an increasing incidence in the United States. In the past 2 decades, the proportion of Americans diagnosed with incurable, metastatic anal cancer at the time of initial presentation has increased. Most cases are linked to prior infection with HPV. Although concurrent chemoradiotherapy has been the accepted standard…

    Source: JNCCN
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of JNCCN
      JNCCN

      Prognostic and Predictive Markers for Patients With #AnalCancer: https://t.co/dTedtNARN5 #ancsm @VanMorrisMD @DrEmmaHolliday @arjunp24 https://t.co/SmZEq97lah

  • Mashup Score: 0
    Predicting All-Cause Mortality in Women With and Without Breast Cancer Using the Schonberg Index: A Women’s Health Initiative Study - 1 year(s) ago

    Background: When treating older women with breast cancer, life expectancy is an important consideration. ASCO recommends calculating 10-year mortality probabilities to inform treatment decisions. One useful tool is the Schonberg index, which predicts risk-based all-cause 10-year mortality. We investigated the use of this index in women aged ≥65 years with breast cancer in the Women’s Health…

    Source: JNCCN
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of JNCCN
      JNCCN

      Predicting All-Cause Mortality in Women With and Without #BreastCancer Using the Schonberg Index: A Women’s Health Initiative Study: https://t.co/QEoebl4Lpd #BCSM @EnriqueSoto8 @Mara_Schonberg @kerryn_reding @MinaSedrakMD @LauraKruperMD https://t.co/SoD4CvwF5b

  • Mashup Score: 1
    Private Payer and Medicare Coverage Policies for Use of Circulating Tumor DNA Tests in Cancer Diagnostics and Treatment - 1 year(s) ago

    Background: Circulating tumor DNA (ctDNA) is used to select initial targeted therapy, identify mechanisms of therapeutic resistance, and measure minimal residual disease (MRD) after treatment. Our objective was to review private and Medicare coverage policies for ctDNA testing. Methods: Policy Reporter was used to identify coverage policies (as of February 2022) from private payers and Medicare…

    Source: JNCCN
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of JNCCN
      JNCCN

      Private Payer & Medicare Coverage Policies for Use of #ctDNA Tests in #Cancer Diagnostics & Treatment: https://t.co/7QH2Wqh15W #cactc #hpeonc @MDouglas_MS @meera_Ragavan @Chenchengclaire @Stacywgray @collin_Blakely @KathrynP_phd @ucsfpharmacy @ucsfprecision @ucsf @UCSF_TRANSPERS https://t.co/H5anh8bXmu

  • Mashup Score: 1
    Real-World Implementation of Best-Evidence Cancer Distress Management: Truly Comprehensive Cancer Care - 1 year(s) ago

    Background: Cancer distress management is an evidence-based component of comprehensive cancer care. Group-delivered cognitive behavioral therapy for cancer distress (CBT-C) is the first distress treatment associated with replicated survival advantages in randomized clinical trials. Despite research supporting patient satisfaction, improved outcomes, and reduced costs, CBT-C has not been tested…

    Source: JNCCN
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of JNCCN
      JNCCN

      Study by researchers at @MayoClinic @MayoPsych advances translation of best-evidence #distressmanagement into accessible, comprehensive care for all patients with #cancer: https://t.co/FPSuRFjX9x #psyonc #supponc @KathrynRuddyMD https://t.co/7bS9f5Uw5G

  • Mashup Score: 10
    Predicting All-Cause Mortality in Women With and Without Breast Cancer Using the Schonberg Index: A Women’s Health Initiative Study - 1 year(s) ago

    Background: When treating older women with breast cancer, life expectancy is an important consideration. ASCO recommends calculating 10-year mortality probabilities to inform treatment decisions. One useful tool is the Schonberg index, which predicts risk-based all-cause 10-year mortality. We investigated the use of this index in women aged ≥65 years with breast cancer in the Women’s Health…

    Source: JNCCN
    Categories: Latest Headlines, Oncologists2
    Tweet Tweets with this article
    • Profile photo of EnriqueSoto8
      EnriqueSoto8

      Our results show that the Schonberg index can indeed be used to predict 10-year all cause mortality for women with #bcsm, tus providing evidence to back the current @ASCO #gerionc recommendations Looking forward to your comments!!! 👇👇👇👇👇👇👇👇👇👇👇👇 https://t.co/t1iG1neJjy

    • Profile photo of EnriqueSoto8
      EnriqueSoto8

      We found that women with #breastcancer #bcsm #gerionc had a similar risk-stratified (by Schonberg index quintiles) 10-year all-cause mortality than those without #bcsm. The Index accurately predicted mortality in both groups (c-index 0.71 & 0.76) @JNCCN https://t.co/t1iG1neJjy https://t.co/zrcTPhe0a1

    • Profile photo of EnriqueSoto8
      EnriqueSoto8

      In this paper, led by Rebecca Nelson we investigated the use of one such tool, the Schonberg Index (@Mara_Schonberg ) in older women with breast cancer (2,549) and paired "controls" without #bcsm and compared risk-stratified mortality rates @JNCCN https://t.co/t1iG1neJjy

    • Profile photo of EnriqueSoto8
      EnriqueSoto8

      Our most recent paper on the use of the Schonberg Index to predict all-cause mortality in older women with breast cancer in the WHI study #bcsm #gerionc is now published in @JNCCN !!!! 👇👇👇👇👇 https://t.co/t1iG1neJjy https://t.co/mcsyq89HRX

  • Mashup Score: 0
    Visa Constraints and Career Choices for Oncologists - 1 year(s) ago

    “Visa Constraints and Career Choices for Oncologists” published on Mar 2023 by National Comprehensive Cancer Network.

    Source: JNCCN
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of HadidiSamer
      HadidiSamer

      Attending @IMG_Oncologists #ASCO23 @ASCO #MedTwitter event on struggles faced by many centered on visa issues, here is a paper we wrote on @JNCCN where we provide proposed solutions to the current problems @FarahMazahreh @ahmadalhader https://t.co/P0j9w4fYfQ

Load More